A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants

NCT07716410 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-07-21

No results posted yet for this study

Summary

This study aims to characterize the pediatric cryptosporidiosis disease profile with respect to clinical presentation.

Conditions

  • Cryptosporidiosis

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Eligibility

Min Age
6 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-09
Primary Completion
2027-05-19
Completion
2027-05-19

Countries

  • Kenya
  • Malaysia
  • Zambia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07716410 on ClinicalTrials.gov